References
- Jones K L, Smith D W. Recognition of fetal alcohol syndrome in early infancy. Lancet 1973; 2: 999–1001
- Jones K L, Smith D W, Ulleland C N, Streissguth A P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973; 1: 1267–1271
- Hannigan J H, Welch R A, Sokol R J. Recognition of fetal alcohol syndrome and alcohol-related birth defects. “Medical Diagnosis and Treatment of Alcoholism.”, J Mendelson, V Mello. McGraw-Hill, New York 1992; 639–667
- Ostrea E M, Jr, Brady M, Gause S, Raymundo A L, Stevens M. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107–113
- Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption. Alcohol Clin Exp Res 1986; 10: 535–544
- Stibler H, Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcohol Clin Exp Res 1987; 11: 468–473
- Gjerde H, Johnsen J, Bjorneboe A, Bjorneboe G-E., Morland J. A comparison of serum carbohydrate-deficient transferrin with other biological markers of excessive drinking. Scand J Clin Lab Invest 1988; 48: 1–6
- Behrens U, Worner T, Braly L, Schaffner F, Lieber C. Carbohydrate-deficient transferrin (CDT), a marker for chronic alcohol consumption in different ethnic populations. Alcohol Clin Exp Res 1988; 12: 427–432
- Stibler H, Borg S. The value of carbohydrate-deficient transferrin as a marker of high alcohol consumption. “Biomedical and Social Aspects of Alcohol and Alcoholism.”, K Kuriyama, A Takada, H Ishii. Elsevier, New York 1988; 503–506
- Schellenberg F, Benard J, Le Goff A, Bourdin C, Weill J. Evaluation of carbohydrate-deficient transferrin compared with Tf index and other markers of alcohol abuse. Alcohol Clin Exp Res 1989; 13: 605–610
- Stibler H, Borg S. Carbohydrate composition of serum transferrin in alcoholic patients. Alcohol Clin Exp Res 1986; 10: 61–64
- Stibler H, Borg S, Joustra M. A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Suppl 1991; 1: 451–454
- Sokol R J, Ager J W, Martier S S. “Methodological Issues in Obtaining and Managing Substance Abuse Information From Prenatal Patients,”. Technical Monograph, National Institute on Drug Abuse, Washington, DC 1992; 80–97
- Bowman R S, Stein L I, Newton J R. Measurement and interpretation of drinking behavior. J Stud Alcohol 1975; 36: 1154–1172
- Hobel C J, Hyvarinen M A, Okada D M, Oh W. Prenatal and intrapartum high-risk screening. Am J Obstet Gynecol 1973; 117: 1–19
- Schacter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 1986; 64: 163–181
- Stibler H, Borg S. Glycoprotein glycosyltransferase activates in serum in alcohol abusing patients. Alcohol Alcohol 1989; 24: 388
- Parker W C, Hagstrom J WC, Bearn A G. Additional studies on the transferrins of cord serum and cerebrospinal fluid. J Exp Med 1963; 975–989
- Yang F, Friedrichs W E, Buchanan J M, Herbert D C, Weaker F J, Brock J H, Bowman B H. Tissue specific expression of mouse transferrin during development and aging. Mech Ageing Dev 1990; 56: 187–197
- Harris E D. New insights into placental iron transport. Nutr Rev 1992; 50: 329–337
- Contractor S F, Eaton B M. Role of transferrin in iron transport between maternal and fetal circulations of perfused lobule of human placenta. Cell Biochem Funct 1986; 4: 69–74
- Kornfeld R, Kornfeld S. The structure of a phytohemagglutinin receptor site from human erythrocytes. J Biol Chem 1970; 245: 2536–2545
- Putnam F. “Transferrin in the Plasma Proteins. Structure, Function and Genetic Control.”. Academic Press, New York 1976; 266–316
- Weinberg E D. Iron and susceptibility to infectious disease. Science 1974; 184: 952